Showing results (2231-2240 of 3,105) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|June 21, 2025
The argument for screening programs in previvors with Li-Fraumeni syndromeMeis Omran, David MalkinExpert Review of Anticancer Therapy|June 21, 2025
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectivesGiuseppe Pelosi, Maria Gemelli, Fabrizio Bianchi, et al.Expert Review of Anticancer Therapy|December 10, 2025
Overcoming toxicity challenges in immune checkpoint inhibitor treatment of high-risk metastatic cancersRishitha Nalabothu, Douglas B JohnsonExpert Review of Anticancer Therapy|December 5, 2025
Unveiling the power of PARP inhibitors: a meta-analysis on newly diagnosed advanced ovarian cancer maintenance therapyWanfang Zhang, Ni Zhang, Shaojie Li, et al.Expert Review of Anticancer Therapy|December 10, 2025
Pretreatment hyperferritinaemia as an independent prognostic marker in metastatic solid tumors treated with immune checkpoint inhibitorsFatma Pinar Açar, Caner Acar, Haydar Çağatay Yüksel, et al.Expert Review of Anticancer Therapy|February 13, 2025
Persisting challenges in the early detection of hepatocellular carcinomaAshwini Arvind, Kennedy Redmon, Amit G SingalExpert Review of Anticancer Therapy|February 12, 2025
An update understanding of stemness and chemoresistance of prostate cancerAfiya Wahab, Hifzur R SiddiqueExpert Review of Anticancer Therapy|December 24, 2024
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancerRiccardo Serra, Emilio Francesco Giunta, Giuseppe Schepisi, et al.Expert Review of Anticancer Therapy|December 16, 2024
Therapeutic patterns and outcomes in older patients (aged≥65 years) with stage III-IVB inoperable oral cavity squamous cell carcinoma (OCSCC): an investigational study from the SEER databaseWangyan Zhong, Hang Yuan, Ting Li, et al.Expert Review of Anticancer Therapy|December 14, 2024
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancerGozde Kavgaci, Taha Koray Sahin, Tugcenur Muderrisoglu, et al.Pageof 311